MICHAEL STRAZZELLA

BUCHANAN INGERSOLL & ROONEY PC · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

12 agencies contacted

Activity

filings by quarter

Works on

Health Issues 49 Budget/Appropriations 36 Medicare/Medicaid 29 Insurance 20 Veterans 17 Medical/Disease Research/Clinical Labs 16 Defense 14 Pharmacy 13 Manufacturing 9 Trade (domestic/foreign) 5 Science/Technology 5 Labor Issues/Antitrust/Workplace 4 Animals 4 Clean Air and Water (quality) 4 Copyright/Patent/Trademark 4 Immigration 4 Agriculture 4 Urban Development/Municipalities 4 Transportation 3

Background

Career

BUCHANAN INGERSOLL & ROONEY PC

Washington, DC

2024 - present

Specific issues

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Health Issues · 2024 Q3

Monitor, evaluate and respond on issues related to residential treatment centers

Medical/Disease Research/Clinical Labs · 2024 Q4

Pharmacy Benefit Manager Transparency Act of 2023 (S.127); American Relief Act, 2025 (PL-118-158)

Pharmacy · 2024 Q4

Pharmacy Benefit Manager Transparency Act of 2023 (S.127); Improving Seniors Timely Access To Care Act; Employee Tax Credit; Medicare Advantage payment issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act; HR 5378, Lower Costs, More Transparency Act; mental health parity; American Relief Act, 2025 (PL-118-158)

Health Issues · 2024 Q4

Pharmacy Benefit Manager Transparency Act of 2023 (S.127); Improving Seniors Timely Access To Care Act; FY 2024 Appropriations projects; Fiscal Responsibility Act; Further Additional Continuing Appropriations and Other Extensions Act, 2024 (Public Law 118-35); Further Consolidated Appropriations Act, 2024 (H.R. 2882); workforce issues; American Relief Act, 2025 (PL-118-158)

Budget/Appropriations · 2024 Q4

Pharmacy Benefit Manager Transparency Act of 2023 (S.127); Improving Seniors Timely Access To Care Act; Medicare Advantage payment issues, from CMS; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Fiscal Responsibility Act; Connect Act; HR 5378, Lower Costs, More Transparency Act; mental health parity; American Relief Act, 2025 (PL-118-158)

Medicare/Medicaid · 2024 Q4